Super Session 4

The Push for Intelligent Capital

21 April 2021

09:15 - 10:30
The Push for Intelligent Capital

Super Session 4

09:15 - 10:30

Innovation & technology are the beating heart of human progress, starting the moment we begin to think and act differently in companies & investments. Our session will begin with a Keynote from the Head of the Life Science Division at the European Investment Bank (EIB), one of the largest supporters of European innovation, as well as one of the largest venture capital providers via the European Investment Fund (EIF). For Europe and the Nordics to remain globally competitive, the EIB’s mandate is clear: go digital, go green, and take the risk.

In the first half of our session, we will tackle the Elevator Pitch, with a ‘twist’. As a start-up, it is often expected that an elevator pitch is ready to deliver on-demand. How do the Pros do it? Meet our team of financial experts across four major funds. Each is here to tell you a bit about their vision, strategy, and ideal fit by offering up their ”Reverse-Elevator Pitch: Investor to SME.”

In 2015, NY Times quoted, “There are more CEOs named John than female CEOs.” Five years later, we see a growing number of female partners in VC firms and corporate leadership roles, but is it enough? In the second half of this session, we have put together a leading panel of female experts who will address the role of gender in financing and corporate development, including how women think and invest differently and how leadership diversity can increase a company’s valuation. Our panel will also tackle other topics, all geared towards helping you hunt wisely for intelligent capital and maximize your chances of success. For example, did you know an investor’s rejection can be a good thing? Expect an interactive dialogue & come with questions!

Sponsored by:

DNB

DNB

Moderator(s): Ms. Isabelle de Cremoux - CEO & Managing Partner, Seventure Partners

Speaker(s):

Ms. Isabelle de Cremoux - CEO & Managing Partner, Seventure Partners
Ms. Felicitas Riedl - Life Science Expert, European Investment Bank
Mr. Stephan Christgau - Founding & Managing Partner, Eir Ventures
Dr. Dina Chaya - Partner, NeoMed Management - Advisor, Omega Funds
Dr. Deborah Harland - Partner at SR One - GSK Venture Capital Group
Ms. Rachel Mears - Deputy Director General, Jeito Capital
Dr. Ingrid Teigland Akay - Managing Partner, Hadean Ventures
Dr. Joanne M. Hackett - Head of Genomic and Precision Medicine EMEA, IQVIA
Dr. Christina Trojel-Hansen - EIR, Arch Venture Partners - Director, Emerson collective, The Steve Jobs family fund
Ms. Jeanne Bolger - Corporate Venture Capital Investor, Johnson & Johnson Innovation – JJDC, inc.

full program